XML 97 R85.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Stock and Reserves - Additional Information (Details)
$ / shares in Units, $ / shares in Units, ¥ in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
HKD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
HKD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
HKD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
CNY (¥)
shares
Jul. 28, 2022
shares
Jun. 23, 2022
shares
Apr. 28, 2022
shares
Sep. 30, 2021
CNY (¥)
May 06, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Share-based compensation costs recorded for the period   $ 5,400,000   $ 6,100,000   $ 19,100,000   $ 18,200,000                
Stock-based compensation expense   $ 5,404,000   $ 6,109,000   $ 19,093,000   $ 18,211,000                
Maximum number of shares of common stock may be issued for outstanding PSU | shares   55,973,443       55,973,443       58,653,642 58,653,642          
Common shares purchased in open market by trustee in connection with RSUs | shares   0 0 0 0 0 0 0                
Number of treasury shares held in trust for future settlement of share based awards | shares           0 0     0 0          
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   6,178,413 6,178,413 6,115,389 6,115,389 6,178,413 6,178,413 6,115,389                
Percentage of statutory net profits to statutory surplus reserve to be appropriated   10.00%       10.00%                    
Discontinuation of contribution, Aggregate sum of statutory surplus reserve more than its registered capital,percent.   50.00%       50.00%                    
Statutory surplus reserve appropriated   $ 0   $ 5,600,000   $ 0   $ 5,600,000 $ 5,600,000           ¥ 36.4  
Dividends declared and paid                   $ 20,400,000 ¥ 131.6          
Statutory surplus reserve to its subsidiaries registered capital percent       50.00%       50.00% 50.00%           50.00%  
Subsequent Event [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Repurchase of common shares | shares 1,129,774                              
Stock Acquired, Average Cost per Share | $ / shares $ 13.96                              
Change in ownership interest related to IMAX China common share repurchases $ 15,800,000                              
IMAX China                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Details of the share repurchase program           In 2021, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of May 6, 2021 (34,835,824 shares). This program expired on the date of the 2022 Annual General Meeting of IMAX China on June 23, 2022. During the 2022 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program will be valid until the 2023 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time. In 2021, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of May 6, 2021 (34,835,824 shares). This program expired on the date of the 2022 Annual General Meeting of IMAX China on June 23, 2022. During the 2022 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program will be valid until the 2023 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.                  
Stock Repurchase Program Expiration Date           Jun. 23, 2022 Jun. 23, 2022 May 06, 2021                
Repurchase of common shares | shares   1,513,800 1,513,800 3,569,000 3,569,000 2,961,800 2,961,800 3,569,000                
Stock Acquired, Average Cost per Share | (per share)   $ 0.79 $ 6.20 $ 1.40 $ 10.90 $ 1.02 $ 8.00 $ 1.40 $ 10.90              
Change in ownership interest related to IMAX China common share repurchases   $ 1,200,000 $ 9,400,000   $ 38.9 $ 3,000,000.0 $ 23,700,000 $ 5.0                
Stock Repurchase Program, maximum percentage of shares to be repurchased                         10.00%     10.00%
Stock Repurchase Program, Authorized number of shares | shares                         34,063,480     34,835,824
Parent [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Details of the share repurchase program           April 28, 2022 and July 28, 2022, the Company's Board of Directors approved a 12-month extension to its share repurchase program through June 30, 2023 and an increase of $200.0 million in the share repurchase program, respectively. With the increase of $200.0 million, the Company's total share repurchase authority is $400.0 million under the current share repurchase program. As of September 30, 2022, the Company has $220.1 million available under its approved repurchased program. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time. April 28, 2022 and July 28, 2022, the Company's Board of Directors approved a 12-month extension to its share repurchase program through June 30, 2023 and an increase of $200.0 million in the share repurchase program, respectively. With the increase of $200.0 million, the Company's total share repurchase authority is $400.0 million under the current share repurchase program. As of September 30, 2022, the Company has $220.1 million available under its approved repurchased program. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.                  
Stock Repurchase Program, Authorized Amount   $ 220,100,000       $ 220,100,000                    
Stock Repurchase Program Expiration Date           Jun. 30, 2023 Jun. 30, 2023                  
Repurchase of common shares | shares   418,496 418,496 316,812 316,812 3,501,696 3,501,696 316,812                
Stock Acquired, Average Cost per Share | $ / shares   $ 14.62   $ 14.53   $ 15.82   $ 14.53                
Change in ownership interest related to IMAX China common share repurchases   $ 6,100,000   $ 4,600,000   $ 55,400,000   $ 4,600,000                
Stock Repurchase Program, Authorized number of shares | shares                       200,000,000.0   200,000,000.0    
Statutory surplus reserve appropriated       3,900,000       3,900,000 $ 3,900,000              
Parent [Member] | Maximum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock Repurchase Program, Authorized Amount   400,000,000.0       400,000,000.0                    
Non-controlling Interests [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Change in ownership interest related to IMAX China common share repurchases   343,000   1,371,000   1,644,000   1,371,000                
Statutory surplus reserve appropriated       1,700,000       1,700,000 $ 1,700,000              
Restricted Share Units [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock-based compensation expense   $ 3,516,000   $ 3,900,000   $ 11,405,000   $ 11,524,000                
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   1,329,014 1,329,014 1,592,965 1,592,965 1,329,014 1,329,014 1,592,965                
Restricted Share Units [Member] | Non-Employee Directors [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock-based compensation expense   $ 0       $ 1,300,000                    
Restricted Share Units [Member] | Non-Employee Directors [Member] | IMAX China                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock-based compensation expense       $ 0       $ 0                
Employee Stock Option [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock-based compensation expense   $ 120,000   $ 253,000   $ 449,000   $ 808,000                
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   3,604,739 3,604,739 3,738,504 3,738,504 3,604,739 3,604,739 3,738,504                
Performance Stock Units [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Stock-based compensation expense   $ 1,864,000   $ 1,183,000   $ 5,317,000   $ 3,169,000                
Stock based awards vesting period           3 years 3 years                  
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units | shares   1,244,660 1,244,660 783,920 783,920 1,244,660 1,244,660 783,920                
Performance Stock Units [Member] | Minimum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage           0.00% 0.00%                  
Performance Stock Units [Member] | Maximum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage           175.00% 175.00%                  
Performance Stock Units [Member] | EBITDA | Maximum [Member]                                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                
Maximum number of shares of common stock may be issued for outstanding PSU | shares   1,636,735       1,636,735